ARCHIVES

Three NCAB Members Say They Cannot Offer “Strong Endorsement” Of P-4 Trial.

This article is from The Cancer Letter archive.

Vol. 33 No. 23 | June 15, 2007

Download PDF Visit The Full Archive

Related Articles

North Central Group Review Postponed While New Committee Formed To Handle All “Regional: Groups

July 10, 1981

NCI Director Halts STELLAR Trial, Seeks “Brilliant Ideas” For Breast Cancer Prevention.

March 2, 2007

The Cancer Letter Wins Investigative Reporting Award

June 8, 2001

Doxil/Caelyx Survival 3 Weeks Longer Than Topotecan

November 28, 2003

CPT Code Changes Confuse Oncologists, Appear To Bloc Some Chemotherapy Payments

April 6, 1990

FDA News: Avastin Combination Approved In Recurrent Ovarian Cancer

November 14, 2014